Skip Nav Destination
A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation
Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma
The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome
Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia
Issue Archive
November 3 2011
In this Issue
Table of Contents
Inside Blood
Blood Work
Plenary Paper
PLENARY PAPER
Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide
Yuan Xiao Zhu,Esteban Braggio,Chang-Xin Shi,Laura A. Bruins,Jessica E. Schmidt,Scott Van Wier,Xiu-Bao Chang,Chad C. Bjorklund,Rafael Fonseca,P. Leif Bergsagel,Robert Z. Orlowski,A. Keith Stewart
Perspectives
Review Article
Clinical Trials and Observations
A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation
Clinical Trials & Observations
Bénédicte Neven,Aude Magerus-Chatinet,Benoit Florkin,Delphine Gobert,Olivier Lambotte,Lien De Somer,Nina Lanzarotti,Marie-Claude Stolzenberg,Brigitte Bader-Meunier,Nathalie Aladjidi,Christophe Chantrain,Yves Bertrand,Eric Jeziorski,Guy Leverger,Gérard Michel,Felipe Suarez,Eric Oksenhendler,Olivier Hermine,Stéphane Blanche,Capucine Picard,Alain Fischer,Frédéric Rieux-Laucat
Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas
Clinical Trials & Observations
Thomas E. Witzig,Hui Tang,Ivana N. M. Micallef,Stephen M. Ansell,Brian K. Link,David J. Inwards,Luis F. Porrata,Patrick B. Johnston,Joseph P. Colgan,Svetomir N. Markovic,Grzegorz S. Nowakowski,Carrie A. Thompson,Cristine Allmer,Matthew J. Maurer,Mamta Gupta,George Weiner,Ray Hohl,Paul J. Kurtin,Husheng Ding,David Loegering,Paula Schneider,Kevin Peterson,Thomas M. Habermann,Scott H. Kaufmann
Gene Therapy
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
Clinical Trials & Observations
Renier J. Brentjens,Isabelle Rivière,Jae H. Park,Marco L. Davila,Xiuyan Wang,Jolanta Stefanski,Clare Taylor,Raymond Yeh,Shirley Bartido,Oriana Borquez-Ojeda,Malgorzata Olszewska,Yvette Bernal,Hollie Pegram,Mark Przybylowski,Daniel Hollyman,Yelena Usachenko,Domenick Pirraglia,James Hosey,Elmer Santos,Elizabeth Halton,Peter Maslak,David Scheinberg,Joseph Jurcic,Mark Heaney,Glenn Heller,Mark Frattini,Michel Sadelain
Hematopoiesis and Stem Cells
Immunobiology
A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens
Helene Pere,Yves Montier,Jagadeesh Bayry,Francoise Quintin-Colonna,Nathalie Merillon,Estelle Dransart,Cecile Badoual,Alain Gey,Patrice Ravel,Elie Marcheteau,Frederic Batteux,Federico Sandoval,Olivier Adotevi,Christopher Chiu,Sylvie Garcia,Corinne Tanchot,Yu-Chun Lone,Luis Carlos Ferreira,Brad H. Nelson,Douglas Hanahan,Wolf Herman Fridman,Ludger Johannes,Eric Tartour
Lymphoid Neoplasia
Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma
Brief Report
Davide Rossi,Silvia Deaglio,David Dominguez-Sola,Silvia Rasi,Tiziana Vaisitti,Claudio Agostinelli,Valeria Spina,Alessio Bruscaggin,Sara Monti,Michaela Cerri,Stefania Cresta,Marco Fangazio,Luca Arcaini,Marco Lucioni,Roberto Marasca,Catherine Thieblemont,Daniela Capello,Fabio Facchetti,Ivo Kwee,Stefano A. Pileri,Robin Foà,Francesco Bertoni,Riccardo Dalla-Favera,Laura Pasqualucci,Gianluca Gaidano
Myeloid Neoplasia
Phagocytes, Granulocytes, and Myelopoiesis
The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome
Clinical Trials & Observations
David H. McDermott,Qian Liu,Jean Ulrick,Nana Kwatemaa,Sandra Anaya-O'Brien,Scott R. Penzak,Joao Oliveira Filho,Debra A. Long Priel,Corin Kelly,Mary Garofalo,Patricia Littel,Martha M. Marquesen,Diane Hilligoss,Rosamma DeCastro,Thomas A. Fleisher,Douglas B. Kuhns,Harry L. Malech,Philip M. Murphy
Red Cells, Iron, and Erythropoiesis
Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats
Igor Theurl,Andrea Schroll,Thomas Sonnweber,Manfred Nairz,Milan Theurl,Wolfgang Willenbacher,Kathrin Eller,Dominik Wolf,Markus Seifert,Chia Chi Sun,Jodie L. Babitt,Charles C. Hong,Tracey Menhall,Patrick Gearing,Herbert Y. Lin,Guenter Weiss
Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia
Clinical Trials & Observations
Russell E. Ware,Jenny M. Despotovic,Nicole A. Mortier,Jonathan M. Flanagan,Jin He,Matthew P. Smeltzer,Amy C. Kimble,Banu Aygun,Song Wu,Thad Howard,Alex Sparreboom
Thrombosis and Hemostasis
Transplantation
Low telomerase activity in CD4+ regulatory T cells in patients with severe chronic GVHD after hematopoietic stem cell transplantation
Yutaka Kawano,Haesook T. Kim,Ken-ichi Matsuoka,Gregory Bascug,Sean McDonough,Vincent T. Ho,Corey Cutler,John Koreth,Edwin P. Alyea,Joseph H. Antin,Robert J. Soiffer,Jerome Ritz
Vascular Biology
Critical role for Syk in responses to vascular injury
Patrick Andre,Toshifumi Morooka,Derek Sim,Keith Abe,Clifford Lowell,Nisha Nanda,Suzanne Delaney,Gail Siu,Yibing Yan,Stan Hollenbach,Anjali Pandey,Huiyun Gao,Yunmei Wang,Kohsuke Nakajima,Sahil A. Parikh,Can Shi,David Phillips,Whyte Owen,Uma Sinha,Daniel I. Simon
Errata
-
Cover Image
Cover Image
Diagrammatic representation of the trophoblast surface covering floating villi within the human placenta. Cytotrophoblast cells (green) at bottom left divide asymmetrically to fuse (top) into the outer syncytiotrophoblast layer that is in direct contact with maternal blood and acts as an anticoagulant surface under normal circumstances. This outer layer may degenerate, resulting in local thrombosis and infarction (yellow) in pathologic high-risk pregnancies (bottom right). Credit: Kenneth Xavier Probst, Sascha Drewlo, and John Kingdom. See the article by Kingdom and Drewlo, page 4780.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals